Literature DB >> 29886490

Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort.

Adam P Mecca1,2,3, Hannah R Michalak1,2, Julia W McDonald1,2, Emily C Kemp1,2, Erika A Pugh1,2, Melinda L Becker1,2, Marcia C Mecca3,4, Christopher H van Dyck1,2,5,6.   

Abstract

BACKGROUND: We investigated the relationship between sleep disturbance and cognitive decline or clinical conversion in individuals with normal cognition (CN), as well as those with mild cognitive impairment (MCI) and dementia due to Alzheimer disease (AD-dementia).
METHODS: Secondary analysis of 1,629 adults between 48 and 91 years of age with up to 24 months of follow-up from the ADNI (Alzheimer's Disease Neuroimaging Initiative), a longitudinal cohort study.
RESULTS: Sleep disturbance was not associated with decline in memory, executive function, or global cognition. The presence of sleep disturbance did not significantly increase the risk of diagnostic conversion in CN, early MCI, or late MCI participants.
CONCLUSION: This study investigated the effect of sleep disturbance on cognitive decline using several outcomes and does not support the hypothesis that sleep disturbance predicts subsequent cognitive decline.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  ADNI; Alzheimer disease; Executive function; Memory; Sleep; Sleep disruption

Mesh:

Year:  2018        PMID: 29886490      PMCID: PMC6178799          DOI: 10.1159/000488671

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  34 in total

Review 1.  Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Authors:  Paul S Aisen; Ronald C Petersen; Michael C Donohue; Anthony Gamst; Rema Raman; Ronald G Thomas; Sarah Walter; John Q Trojanowski; Leslie M Shaw; Laurel A Beckett; Clifford R Jack; William Jagust; Arthur W Toga; Andrew J Saykin; John C Morris; Robert C Green; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

2.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

3.  Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.

Authors:  M E Peters; P B Rosenberg; M Steinberg; M C Norton; K A Welsh-Bohmer; K M Hayden; J Breitner; J T Tschanz; C G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

4.  Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease.

Authors:  Gianfranco Spalletta; Jeffrey D Long; Robert G Robinson; Alberto Trequattrini; Sonia Pizzoli; Carlo Caltagirone; Maria D Orfei
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

5.  Sleep Quality and Risk of Dementia Among Older Male Veterans.

Authors:  Kristine Yaffe; Jasmine Nettiksimmons; Jerome Yesavage; Amy Byers
Journal:  Am J Geriatr Psychiatry       Date:  2015-02-21       Impact factor: 4.105

Review 6.  Statins, cognition, and dementia—systematic review and methodological commentary.

Authors:  Melinda C Power; Jennifer Weuve; A Richey Sharrett; Deborah Blacker; Rebecca F Gottesman
Journal:  Nat Rev Neurol       Date:  2015-03-24       Impact factor: 42.937

7.  Sleep disturbance in dementia with Lewy bodies and Alzheimer's disease: a multicenter analysis.

Authors:  Donald L Bliwise; Nathaniel D Mercaldo; Alon Y Avidan; Bradley F Boeve; Sophia A Greer; Walter A Kukull
Journal:  Dement Geriatr Cogn Disord       Date:  2011-04-07       Impact factor: 2.959

8.  Aβ amyloid, cognition, and APOE genotype in healthy older adults.

Authors:  Yen Ying Lim; Kathryn A Ellis; David Ames; David Darby; Karra Harrington; Ralph N Martins; Colin L Masters; Christopher Rowe; Greg Savage; Cassandra Szoeke; Victor L Villemagne; Paul Maruff
Journal:  Alzheimers Dement       Date:  2012-11-14       Impact factor: 21.566

9.  Self-reported sleep and β-amyloid deposition in community-dwelling older adults.

Authors:  Adam P Spira; Alyssa A Gamaldo; Yang An; Mark N Wu; Eleanor M Simonsick; Murat Bilgel; Yun Zhou; Dean F Wong; Luigi Ferrucci; Susan M Resnick
Journal:  JAMA Neurol       Date:  2013-12       Impact factor: 18.302

10.  Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial.

Authors:  Sharon Ooms; Sebastiaan Overeem; Kees Besse; Marcel Olde Rikkert; Marcel Verbeek; Jurgen A H R Claassen
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

View more
  5 in total

1.  Statin Use and Risk of Cognitive Decline in the ADNI Cohort.

Authors:  Emily C Kemp; Megan K Ebner; Srinath Ramanan; Tyler A Godek; Erika A Pugh; Hugh H Bartlett; Julia W McDonald; Marcia C Mecca; Christopher H van Dyck; Adam P Mecca
Journal:  Am J Geriatr Psychiatry       Date:  2019-11-11       Impact factor: 4.105

2.  Sleep Disturbance in Mild Cognitive Impairment and Association With Cognitive Functioning. A Case-Control Study.

Authors:  Katie Palmer; Micaela Mitolo; Francesca Burgio; Francesca Meneghello; Annalena Venneri
Journal:  Front Aging Neurosci       Date:  2018-11-09       Impact factor: 5.750

Review 3.  Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Maria Casagrande; Giuseppe Forte; Francesca Favieri; Ilaria Corbo
Journal:  Int J Environ Res Public Health       Date:  2022-07-11       Impact factor: 4.614

4.  Interactions between sleep disturbances and Alzheimer's disease on brain function: a preliminary study combining the static and dynamic functional MRI.

Authors:  Kaicheng Li; Xiao Luo; Qingze Zeng; Yerfan Jiaerken; Shuyue Wang; Xiaopei Xu; Xiaojun Xu; Jingjing Xu; Chao Wang; Jiong Zhou; Peiyu Huang; Minming Zhang
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

Review 5.  Sleep and its regulation: An emerging pathogenic and treatment frontier in Alzheimer's disease.

Authors:  Brianne A Kent; Howard H Feldman; Haakon B Nygaard
Journal:  Prog Neurobiol       Date:  2020-08-30       Impact factor: 11.685

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.